Science Pool

Evotec

Recent Posts

Turning the Crank using a Hybrid Continuous Purification Platform

Posted by Evotec on Jun 26, 2024 4:30:04 PM

Download our presentation from Recovery of Biological Products XX titled “Turning the crank using a hybrid continuous purification platform” from Michelle Najera, Megan McClure, Shahbaz Gardezi and Beth Larimore. 

Learn how:

  1. Process intensification solutions for monoclonal antibodies, Fc-fusion proteins and bispecific antibodies t ease liquid handling pain points.
  2. Our J.CHOTM High Expression System is delivering perfusion permeate titers of over 2 g/L/d over 25 days.
  3. Continuous capture chromatography significantly enhances resin utilization
  4. Two tank virus inactivation steps can be developed with bench-scale models

Download the Presentation

 

Tags: Oncology, Presentations, Formulation & CMC, Biologics, IND Enabling Studies/Preclinical Development, Immunology & Inflammation, Rare Diseases

Watch on Demand Webinar - Assessing Transporter DDI Risk During Drug Discovery and Development​

Posted by Evotec on Jun 26, 2024 3:20:42 PM

Watch our webinar by expert Rob Elsby on assessing transporter risk during drug discovery and development.

Watch Now

Tags: Videos & Webinars, ADME/DMPK

DoE Approach Applied to (TSWG) Platform: A Case Study

Posted by Evotec on Jun 24, 2024 2:56:30 PM

Tags: Videos & Webinars

It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery

Posted by Evotec on Jun 24, 2024 2:55:56 PM

Tags: Videos & Webinars, Hit & Target ID/Validation

Quality Risk Management

Posted by Evotec on Jun 24, 2024 2:55:15 PM

Tags: Videos & Webinars

Application of Design of Experiments in API Chemical Development

Posted by Evotec on Jun 24, 2024 2:29:19 PM

Tags: Videos & Webinars

Rescuing the Unsolvable – A Case Study

Posted by Evotec on Jun 24, 2024 2:27:57 PM

Tags: Videos & Webinars, Biologics

Conversion of Fed-Batch to Continuous Bioprocess

Posted by Evotec on Jun 24, 2024 2:26:14 PM

Tags: Videos & Webinars, Biologics

Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery

Posted by Evotec on Jun 24, 2024 2:19:14 PM

Tags: Videos & Webinars, Hit & Target ID/Validation

Involving clinicians in model-based designs with Non-DLT Adverse Events Integration: A safer approach to increase the performance of dose-escalation Phase I cancer trials

Posted by Evotec on Jun 20, 2024 4:36:38 PM

This poster relates to enhancing dose selection in phase I cancer trials.

Learn More

Tags: Oncology, Posters